Five Russian startups – the winners of the Startup Challenge accelerator organised jointly by the Skolkovo Foundation and multinational pharma giant AstraZeneca – are showcasing their inventions at the International Future Healthcare Forum in the...
Russia’s first commercial research biobank, National BioService , opened a brand new laboratory at the Skolkovo Technopark on Thursday. The National BioService lab at the Skolkovo Technopark will be used for both the company's own research and...
Pharm-Sintez.Lab , a resident startup of the Skolkovo Foundation’s nuclear cluster, has developed a system for detecting rare forms of cancer in Russian patients. Lev Voloznev, CEO of Pharm-Sintez.Lab, pictured in his lab at the Skolkovo Technopark...
“What’s Russia famous for? The Kalashnikov – the AK47,” says Vladimir Mironov, chief scientific officer at 3D Bioprinting Solutions . “Well now we have a different motto: not shoot to kill, but shoot to heal – using a tissue...
Prime Minister Dmitry Medvedev says Skolkovo is starting to produce tangible results, despite being less than five years old. From left: Skolkovo president Victor Vekselberg, his advisor Pekka Viljakainen, and Prime Minister Medvedev. Photo: sk.ru ...
Improvements in this version of Startup Village: Record crowds, new setting, creative catering. Like the leading smartphone apps, Startup Village is constantly evolving. The third edition of Russia and Eastern Europe’s biggest startup event is no...
ALMATY, Kazakhstan - The Kazakh stage of the Startup Tour concluded on Friday with several innovations winning a place at the Startup Village in June and, perhaps more significantly, the foundations put in place for of a new era of high-tech cooperation between...
It took his grandfather’s brush with death to turn Leonid Glushchenko into an innovator. He was a fresh-faced, 21-year-old medical student at a university on the Volga River when the pensioner developed a life-threatening blood clot. Saving Pyotr...
A 30 million ruble grant from the Skolkovo Foundation is helping a team of Russian scientists develop potentially one of the most effective drugs yet to fight cardiovascular disease – the primary cause of death in Russia and the wider world. Dmitry...